Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof

a technology of bradeion protein and coding protein, which is applied in the field of human-derived bradeion protein, can solve the problems of not being able to fully clarify the stimulating factors involved in brain-specific signal transduction and receptors thereof, not being able to systematically screen substances, and not being able to fully clarify the elements at substance or molecule level

Inactive Publication Date: 2006-03-09
NAT INST OF ADVANCED IND SCI & TECH
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0022] The present invention further provides a host cell that has been transformed or transfected with such a vector. The host c...

Problems solved by technology

However, none of the elements was clarified in the substance or molecule level, and, prior to everything, it was necessary to develop techniques for analysis.
However, such ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
  • Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
  • Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Cloning and Sequencing of cDNA Coding for Human Bradeion

[0073] First, a cDNA library from a human adult brain was constructed using the plasmid vector pCMV SPORT1 (Life Technologies, Inc., USA) which is capable of linking with a CMV promoter for expressing in an eukaryotic cell. The adult brain was obtained from a 36-year-old white Caucasian American female, and mRNA (poly(A) RNA) was extracted therefrom with TRIzol® reagent (Life Technologies, Inc.) and purified with MESSAGEMAKER® reagent (Life Technologies, Inc.). Then double stranded cDNA synthesis and library construction were initiated by SuperScript plasmid system.

[0074] The prepared mRNA (poly(A) RNA) was linked with NotI primer adapter at its 3′-terminus. Then, a double stranded cDNA was synthesized according to a standard method using Superscript II reverse transcriptase and T4 DNA polymerase. The 5′-terminus of the cDNA was linked with SalI adapter and 3′-terminus was treated with NotI restriction enzyme so that the cDNA...

example 2

Characterization of Bradeion α and Bradeion β Proteins

(1) Hydropathy Analysis

[0081] The amino acid sequences of Bradeion α and β proteins determined in Example 1 were subjected to hydropathy analysis by Kyte-Doolittle method (Kyte, J. and Doolittle, R. F. J., J. Mol. Biol., 1982, 157 (1): 105-132). This analysis is one method for predicting a high-order structure of a protein based on its amino acid sequence, whereby the distributions of hydrophobic and hydrophilic portions of the protein can be determined. This analysis therefore allows to study the presence of a three-dimentional structure or a transmembranous domain. FIGS. 1A and 1B show the results of the analysis for the bradeion proteins as well as the results for human-derived IL (interleukin) 2, IL3 and IL4 receptors and growth hormone receptor for comparison. Referring to the figures, the proteins having the sequences of growth hormone and cytokine receptors may be divided roughly into three sections, i.e., an assembly o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Cell deathaaaaaaaaaa
Login to view more

Abstract

A human-derived bradeion protein, which has the following properties: (i) it is a transmembranous protein; (ii) it has a structure characteristic of growth hormone and cytokine receptors even in a structure of its transmembranous portion when its structure is determined by a hydrophobicity analysis according to Kyte-Doolittle method; (iii) it is expressed at a high level in a human adult brain, and in less amount in the heart, while it is not expressed in other adult organs or fetus; (iv) it induces programmed cell death (apoptosis) when over-expressed in a cultured human nerve cell lines; (v) it induces termination of cell division and aging when over-expressed in a cultured human normal cell; (vi) it is located in cytoplasm, and forms an intracellular aggregate when overexpressed; and (vii) besides human adult neurons, it is specifically expressed in a human colorectal cancer cell line or in a skin cancer cell line, or an analogue thereof.

Description

FIELD OF THE INVENTION [0001] The present invention relates to a protein involved in long-term survival of cranial nerve-cell, to DNA encoding the protein, and to uses thereof. More particularly, the present invention relates to human-derived bradeion protein or derivatives thereof, to DNA encoding the protein or the derivatives thereof, to a vector containing the DNA, to a host cell transformed or transfected with the vector, to an antibody immunologically reactive with the protein or the derivatives thereof, and to uses of the DNA or the antibody for detecting a cancer. BACKGROUND OF THE INVENTION [0002] Cranial nerve cells (neurons) are main elements for controlling survival of higher order animals. Once the neurons are produced, they do not divide at all and only gradually exfoliate or go through necrosis. Exfoliation of the neurons occurs in the normal state but is particularly accelerated by genetic diseases, brain ischemia, or status epilepticus, or under conditions of poor n...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/68C07H21/04C07K14/72C07K14/82C12N15/09C07K14/47C07K14/71C07K14/715C07K16/28C12N1/15C12N1/19C12N1/21C12N5/10C12N15/00C12P21/02C12P21/08C12R1/91G01N33/53G01N33/566G01N33/574G01N33/577
CPCC07K14/4747C07K14/71C07K14/715C12Q1/6886G01N33/57419G01N33/5743C12Q2600/158
Inventor TANAKA, MANAMITANAKA, TOMOO
Owner NAT INST OF ADVANCED IND SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap